Institutional Repository UDD

TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features.

Show simple item record

dc.contributor.author Ballestrini, Simona
dc.contributor.author Mathieu, Milh
dc.contributor.author Castiglioni, Claudia
dc.contributor.author Lüthy, Kevin
dc.contributor.author Finelli, Mattea
dc.contributor.author Verstreken, Patrik
dc.contributor.author Cardon, Aaron
dc.contributor.author Gnidovec, Barbara
dc.contributor.author Holder, Lloyd
dc.contributor.author Lesca, Gaetan
dc.contributor.author Mancardi, María
dc.contributor.author Poulat, Anne
dc.contributor.author Repetto, Gabriela
dc.contributor.author et al.
dc.date.accessioned 2017-01-04T15:12:33Z
dc.date.available 2017-01-04T15:12:33Z
dc.date.issued 2016
dc.identifier.citation Neurology, July 2016, vol.87, n°1,p.77-85
dc.identifier.uri http://hdl.handle.net/11447/919
dc.identifier.uri http://dx.doi.org/10.1212/WNL.0000000000002807
dc.description Centro e Genética y Genómica
dc.description.abstract OBJECTIVE: To evaluate the phenotypic spectrum associated with mutations in TBC1D24. METHODS: We acquired new clinical, EEG, and neuroimaging data of 11 previously unreported and 37 published patients. TBC1D24 mutations, identified through various sequencing methods, can be found online (http://lovd.nl/TBC1D24). RESULTS: Forty-eight patients were included (28 men, 20 women, average age 21 years) from 30 independent families. Eighteen patients (38%) had myoclonic epilepsies. The other patients carried diagnoses of focal (25%), multifocal (2%), generalized (4%), and unclassified epilepsy (6%), and early-onset epileptic encephalopathy (25%). Most patients had drug-resistant epilepsy. We detail EEG, neuroimaging, developmental, and cognitive features, treatment responsiveness, and physical examination. In silico evaluation revealed 7 different highly conserved motifs, with the most common pathogenic mutation located in the first. Neuronal outgrowth assays showed that some TBC1D24 mutations, associated with the most severe TBC1D24-associated disorders, are not necessarily the most disruptive to this gene function. CONCLUSIONS: TBC1D24-related epilepsy syndromes show marked phenotypic pleiotropy, with multisystem involvement and severity spectrum ranging from isolated deafness (not studied here), benign myoclonic epilepsy restricted to childhood with complete seizure control and normal intellect, to early-onset epileptic encephalopathy with severe developmental delay and early death. There is no distinct correlation with mutation type or location yet, but patterns are emerging. Given the phenotypic breadth observed, TBC1D24 mutation screening is indicated in a wide variety of epilepsies. A TBC1D24 consortium was formed to develop further research on this gene and its associated phenotypes.
dc.language.iso en_US
dc.publisher Lippincott Williams & Wilkins
dc.subject Infantile myoclonic epilepsy
dc.subject Epilepsy
dc.subject Doors syndrome
dc.subject Hearing loss
dc.subject Neurodegeneration
dc.title TBC1D24 genotype-phenotype correlation: Epilepsies and other neurologic features.
dc.type Artículo


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account